Searched over 200M research papers for "genetic diabetes"
10 papers analyzed
These studies suggest that genetic factors play a significant role in both type 1 and type 2 diabetes, with advances in genomic analysis leading to better understanding, personalized treatments, and potential preventive measures.
20 papers analyzed
Diabetes mellitus, commonly referred to as diabetes, is a chronic metabolic disorder characterized by high blood sugar levels. It is a leading cause of mortality and morbidity worldwide, with significant genetic components influencing its onset and progression. This article synthesizes recent research on the genetic underpinnings of diabetes, focusing on both type 1 and type 2 diabetes, as well as the genetic factors contributing to diabetes complications.
Type 1 diabetes (T1D) is primarily an autoimmune disorder where the body's immune system attacks insulin-producing beta cells in the pancreas. Genetic predisposition plays a crucial role in T1D, with the human leukocyte antigen (HLA) genes on chromosome 6 being the most significant contributors, accounting for about half of the genetic risk . Other non-HLA genes also contribute to the disease, although their individual impacts are smaller.
Recent studies have identified rare genetic variants with large effects on T1D risk. For instance, a rare variant in the STK39 gene has been shown to significantly increase the risk of T1D, highlighting the importance of rare genetic factors in the disease's etiology.
Type 2 diabetes (T2D) is a multifactorial disease influenced by both genetic and environmental factors. Unlike monogenic disorders, T2D involves multiple genetic variants, each contributing a small effect. Genome-wide association studies (GWAS) have identified numerous common variants associated with T2D, but these explain only a fraction of the disease's heritability .
While common variants have been extensively studied, recent research suggests that low-frequency variants also play a role in T2D. However, large-scale sequencing studies indicate that these variants do not have a major impact on T2D predisposition, emphasizing the complexity of the disease's genetic architecture.
There is evidence of overlapping genetic regions associated with both T1D and T2D. For example, variants near the GLIS3 gene have been found to increase the risk of both diseases, suggesting shared genetic mechanisms at the level of pancreatic beta cells. However, most shared genetic signals have opposite effects on the two diseases, indicating a complex genetic relationship.
Diabetes complications, such as cardiovascular disease, diabetic kidney disease, retinopathy, and neuropathy, also have genetic components. Recent genomic studies have more than doubled the number of genetic loci associated with these complications, providing new insights into their pathogenesis. Understanding these genetic factors is crucial for predicting and managing diabetes complications.
Identifying genetic risk variants is a promising approach towards personalized diabetes management. By understanding the unique genetic and environmental factors influencing an individual's disease, personalized treatment strategies can be developed to improve clinical outcomes and prevent complications.
The genetic landscape of diabetes is complex, involving numerous common and rare variants that contribute to the risk and progression of both type 1 and type 2 diabetes. Advances in genomic research have significantly expanded our understanding of these genetic factors, paving the way for personalized treatment approaches and better management of diabetes and its complications. Future research will continue to unravel the intricate genetic architecture of diabetes, offering new avenues for therapeutic interventions.
Most relevant research papers on this topic